Description |
Toosendanin, a triterpenoid extracted from the bark of fruit of Melia toosendan Sieb et Zucc, possesses analgesic, insecticidal and anti-inflammatory activities[1].
|
In Vivo |
Toosendanin (0.5 and 1 mg/kg, Intraperitoneal injection daily for 7 days) alleviates DSS-induced experimental colitis by inhibiting M1 macrophage polarization and regulating NLRP3 inflammasome and Nrf2/HO-1 signaling, and may provide a novel Chinese patent medicine for the treatment of murine colitis[1]. Animal Model: Forty-eight male C57BL/6 mice weighing 20-22 g[1]. Dosage: 0.5 and 1 mg/kg. Administration: Intraperitoneal injection daily for 7 days. Result: Protected against DSS-induced colitis in mice. Inhibited the expression of proinflammatory cytokines in DSS-induced UC and improved oxidative stress.
|
Density | 1.4±0.1 g/cm3 |
Boiling Point | 714.0±60.0 °C at 760 mmHg |
Flash Point | 385.6±32.9 °C |
Exact Mass | 574.241394 |
PSA | 165.26000 |
LogP | -0.38 |
Vapour Pressure | 0.0±2.4 mmHg at 25°C |